Find the funding your business is owed

€6M – €39.3Mnon-repayable

Call for proposals to address the significant sex and gender disparities in cardiovascular diseases (CVDs), which accounted for over 1.

European Union

Call for proposals to address the significant sex and gender disparities in cardiovascular diseases (CVDs), which accounted for over 1.7 million deaths (32% of all deaths) in the EU in 2021. With a total budget of EUR 39.30 million, the call offers individual awards between EUR 6.00 and 7.00 million to support projects that translate basic biological discoveries into innovative prevention, diagnosis, and treatment strategies tailored to specific physiological and sociocultural needs. Proposals are expected to further the understanding of structural, hormonal, and biological distinctions between sexes. Key focus areas include: Tailored Risk Models: Developing sex-specific models for better disease detection and prevention; Determinant Identification: Validating health determinants by integrating data from disciplines like molecular biology, genetics, and social epidemiology; Data Integration: Utilizing existing health registries, cohorts, and biobanks while ensuring any new data adheres to FAIR principles; and Technological Innovation: Encouraging the use of advanced tools, including Generative AI, to support research outcomes.

€6M – €39.3Mnon-repayable

Call for proposals to support projects that aim at mitigating the long-term health and economic impacts of persistent conditions resulting from microbial infections (excluding cancer).

European Union

Call for proposals to support projects that aim at mitigating the long-term health and economic impacts of persistent conditions resulting from microbial infections (excluding cancer). With a total budget of EUR 39.30 million, this initiative seeks to award individual grants between EUR 6.00 and 8.00 million to projects that improve the prevention, diagnosis, and management of these often underdiagnosed conditions. Proposals should adopt a multidisciplinary approach to identify risk and protective factors—such as genetics and inflammatory responses—and increase our understanding of disease pathophysiology. Key research areas include: Developing clinically validated diagnostic tools and biomarkers; Conducting early-stage clinical trials for preventive or therapeutic interventions; Identifying effective rehabilitation strategies, including physical and cognitive therapies; and Integrating disease management into primary and specialized healthcare settings.

Call for proposals to support projects that to address the significant challenge of low-value care, which is estimated to account for up to one-fifth of global healthcare spending.

European Union

Call for proposals to support projects that to address the significant challenge of low-value care, which is estimated to account for up to one-fifth of global healthcare spending. With a total budget of €38 million and individual awards expected around €10 million, the initiative seeks to develop evidence-based methodologies to identify, measure, and reduce wasteful medical practices. By reallocating these resources, the program aims to maximize health outcomes, improve the resilience of care systems, and reduce the environmental footprint of healthcare delivery. Selected projects must adopt a patient-centered, multidisciplinary approach to achieve the following: Identification and Measurement: Develop a deep understanding of how to detect low-value care throughout the healthcare process, including testing specific indicators for overuse, misuse, and unwarranted variation; Innovative Strategies: Pilot and scale effective strategies for reducing low-value care across diverse European settings, ensuring these solutions are transferable across different healthcare systems; Systems Analysis: Examine healthcare payment and financing models to determine if they unintentionally incentivize low-value care and evaluate alternative models that align with high-value patient outcomes; and Technological Integration: Utilize data models, digital tools, and artificial intelligence to identify inefficiencies and facilitate collaboration between international health registries and databases.

Call for proposals to conduct a comprehensive review of cardiovascular research and innovative healthcare solutions at national, EU, and international levels.

European Union

Call for proposals to conduct a comprehensive review of cardiovascular research and innovative healthcare solutions at national, EU, and international levels. With a total funding allocation of €1.90 million, this initiative aims to identify critical gaps in the field and establish a Strategic Research and Innovation Agenda (SRIA) to improve risk prediction, early detection, and screening for cardiovascular diseases (CVDs) and associated comorbidities like obesity and diabetes. Cardiovascular diseases currently represent the leading cause of death in the EU, accounting for over 1.7 million deaths annually and consuming approximately 11% of healthcare budgets, totaling €282 billion. The proposal is designed to support the upcoming EU Cardiovascular Health plan by integrating digital tools, Virtual Human Twins (VHT), and AI-driven methods. Key activities include: Gap Analysis and Mapping: Conducting a global review of research and innovation, with specific emphasis on addressing sex- and gender-related gaps in diagnosis and treatment; Overcoming Barriers: Generating a detailed report on the obstacles to personalized prevention and providing evidence-based recommendations to bypass these challenges; Inclusive Research Design: Integrating variables such as age, genetic predisposition, lifestyle, and racial or ethnic origin into data analysis to ensure findings are generalizable across diverse populations; Stakeholder Collaboration: Organizing multi-sectoral events to align healthcare providers, researchers, and policymakers, while involving Social Sciences and Humanities (SSH) experts to enhance societal impact.

Call for proposals to support the Public Procurement of Innovative Solutions (PPI) within European health systems.

European Union

Call for proposals to support the Public Procurement of Innovative Solutions (PPI) within European health systems. With a total budget of €24.50 million and individual awards ranging from €3.00 to €8.00 million, the initiative aims to bridge the gap between clinical needs and market-ready innovations. Unlike traditional research grants, this funding specifically targets consortia of procurers—such as hospitals and health authorities—to deploy solutions that facilitate the integration and coordination of care, ultimately making healthcare more personalized, accessible, and inclusive. Proposals must center on the deployment of organizational or technological innovations, such as Artificial Intelligence (AI) for hospital-to-home care coordination or advanced diagnostic tools for personalized medicine. The call prioritizes several vulnerable and high-need groups, including: Vulnerable Patients: Children, the elderly, and frail individuals with complex social and health needs; Chronic & Complex Conditions: People living with multi-morbidities, cancer, rare diseases, or concurrent physical and mental health conditions: and Inclusive Design: Applicants must account for gender and intersectional factors, such as caregiving responsibilities and socioeconomic health disparities, to ensure equitable access.

Call for proposals to modernize the regulatory science governing health technologies within the EU.

European Union

Call for proposals to modernize the regulatory science governing health technologies within the EU. With a total budget of €19.60 million and awards ranging from €4.00 to €6.00 million, the initiative focuses on updating methodologies for clinical evaluation and regulatory assessment. The goal is to ensure that legal frameworks keep pace with rapid innovation in areas such as artificial intelligence (AI), virtual human twins, and new approach methodologies (NAMs), while maintaining rigorous safety and performance standards. Proposals should target the improvement of existing methodologies or explore how novel information sources can provide satisfactory evidence for regulatory needs. Key focus areas include: Refining Evidence Requirements: Closing gaps in clinical evidence clarity and sufficiency for medical devices, in-vitro diagnostics, and substances of human origin (SoHO); Integrating Digital & Bio-medical Approaches: Examining how AI-enabled models, Real-World Data (RWD), and disease-relevant biophysical data can support clinical investigations and predict biological parameters; Optimizing Study Design: Using existing data to improve the planning of first-in-human studies, thereby enhancing participant safety and rationalizing resource use; and Special Populations & Unmet Needs: Exploring regulatory pathways, such as regulatory sandboxes, to accelerate the uptake of technologies for rare diseases and pediatric conditions.